Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two 1 mg entecavir film-coated tablet formulations under fasting in healthy Thai volunteers
TCTR20180919004Phase 4Not yet recruiting
- Sponsor
- Korea United Pharm Inc.
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Korea United Pharm Inc.. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20180919004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180919004.